AR093424A1 - Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso - Google Patents

Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso

Info

Publication number
AR093424A1
AR093424A1 ARP130104119A ARP130104119A AR093424A1 AR 093424 A1 AR093424 A1 AR 093424A1 AR P130104119 A ARP130104119 A AR P130104119A AR P130104119 A ARP130104119 A AR P130104119A AR 093424 A1 AR093424 A1 AR 093424A1
Authority
AR
Argentina
Prior art keywords
methods
haemolytica
vaccines
elaboration
attached
Prior art date
Application number
ARP130104119A
Other languages
English (en)
Inventor
K Lawrence Paulraj
R Simonson Randy
F Bey Russell
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of AR093424A1 publication Critical patent/AR093424A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Cepas atenuadas de M. haemolytica que provocan respuestas inmunes contra M. haemolytica en los animales. Composiciones que comprenden dichas cepas. Métodos de vacunación contra M. haemolytica donde se las emplea. Conjuntos de elementos que pueden usarse con dichos métodos y con dichas composiciones. Vacunas multivalentes que confieren inmunidad de protección cuando se las administra en una cantidad eficaz en animales susceptibles a la fiebre del transporte o a las enfermedades respiratorias propias de los bovinos. Reivindicación 18: Una bacteria que presenta una mutación de supresión en la localización del gen IktCA, que codifica una acilasa (lktC) y la leucotoxina A (lktA).
ARP130104119A 2012-11-08 2013-11-08 Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso AR093424A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261723979P 2012-11-08 2012-11-08

Publications (1)

Publication Number Publication Date
AR093424A1 true AR093424A1 (es) 2015-06-03

Family

ID=50685318

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130104119A AR093424A1 (es) 2012-11-08 2013-11-08 Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso

Country Status (9)

Country Link
US (8) US9370561B2 (es)
EP (2) EP3384927B1 (es)
AR (1) AR093424A1 (es)
AU (2) AU2013342269B2 (es)
BR (1) BR112015010364B1 (es)
CA (1) CA2890466C (es)
ES (1) ES2684556T3 (es)
HK (2) HK1258694A1 (es)
WO (1) WO2014074817A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2890466C (en) 2012-11-08 2022-07-19 Merial, Inc. Attenuated mannheimia haemolytica vaccines and methods of making and use
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
US11690901B2 (en) 2020-03-03 2023-07-04 The United States Of America, As Represented By The Secretary Of Agriculture Southern cattle tick vaccine product
CN115960184B (zh) * 2022-09-28 2023-12-12 华中农业大学 一种溶血性曼氏杆菌a6血清型白细胞毒素抗原蛋白、其抗体及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス　セラム　ラボラトリ−ズ　コミツシヨン 抗原活性を有するアミノ酸配列
US5055400A (en) 1986-11-26 1991-10-08 University Of Guelph Leukotoxin gene of pasteurella haemolytica
CA2014033C (en) 1989-04-07 1993-02-09 Stephen D. Acres Compositions and treatments for pneumonia in animals
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
AUPN631395A0 (en) 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(II)
US5840556A (en) 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
ES2241042T3 (es) 1996-10-11 2005-10-16 The Regents Of The University Of California Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
AU6969798A (en) 1997-04-15 1998-11-11 Baylor College Of Medicine (pasteurella haemolytica) vaccine
US5824556A (en) 1997-06-11 1998-10-20 Tarr; George E. Peptide mass ladders generated using carbon disulfide
WO1999015670A1 (en) * 1997-09-25 1999-04-01 Biotechnology Research And Development Corporation LKTA DELETION MUTANT OF $i(P. HAEMOLYTICA)
US6936262B2 (en) 1997-09-25 2005-08-30 Biotechnology Research And Development Corporation LktA deletion mutant of P. haemolytica
JP4144272B2 (ja) * 2002-07-10 2008-09-03 トヨタ自動車株式会社 内燃機関の燃料噴射量制御装置
DE602004003582T2 (de) 2003-07-02 2007-09-20 Biotechnology Research And Development Corp., Peoria Akapsuläre i p. multocida hyae deletionsmutanten
US9102925B2 (en) 2009-02-02 2015-08-11 Washington State University Compositions and methods for treating or preventing conditions and diseases associated with Mannheimia haemolytica
CA2890466C (en) * 2012-11-08 2022-07-19 Merial, Inc. Attenuated mannheimia haemolytica vaccines and methods of making and use
US20170022510A1 (en) 2012-11-08 2017-01-26 Biotechnology Research And Development Corporation Attenuated Mannheimia haemolytica

Also Published As

Publication number Publication date
BR112015010364B1 (pt) 2022-05-03
EP3384927A1 (en) 2018-10-10
US20160243212A1 (en) 2016-08-25
ES2684556T3 (es) 2018-10-03
HK1258694A1 (zh) 2019-11-15
US10058601B2 (en) 2018-08-28
WO2014074817A2 (en) 2014-05-15
EP2916863B1 (en) 2018-05-30
BR112015010364A2 (pt) 2017-08-22
US9744226B2 (en) 2017-08-29
AU2017202354B2 (en) 2019-02-21
EP3384927B1 (en) 2022-07-06
US20160199477A1 (en) 2016-07-14
WO2014074817A3 (en) 2015-07-02
US20160158336A1 (en) 2016-06-09
US9370561B2 (en) 2016-06-21
US20140170190A1 (en) 2014-06-19
AU2017202354A1 (en) 2017-05-11
CA2890466A1 (en) 2014-05-15
CA2890466C (en) 2022-07-19
AU2013342269A1 (en) 2015-06-04
US9675682B2 (en) 2017-06-13
US20170246286A1 (en) 2017-08-31
US20190000954A1 (en) 2019-01-03
US20170304424A1 (en) 2017-10-26
US10039819B2 (en) 2018-08-07
EP2916863A2 (en) 2015-09-16
HK1209317A1 (en) 2016-04-01
AU2013342269B2 (en) 2017-02-02
US20170128560A1 (en) 2017-05-11

Similar Documents

Publication Publication Date Title
MX2017009308A (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
PH12020500101A1 (en) Novel muscosal adjuvants and delivery systems
TW200806316A (en) Yeast-based vaccine for inducing an immune response
MX2019008564A (es) Composiciones inmunogenicas para su uso en vacunas neumococicas.
BR112014032636A2 (pt) Vacinas atenuadas de streptococcus suis e métodos de produção e usos das mesmas
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
MX2011010976A (es) Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion.
MX2013014485A (es) Vacuna bovinas y metodos.
BR112015021523A8 (pt) composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
CA2915027A1 (en) Compositions and methods for administration of vaccines against dengue virus
BRPI0918806A2 (pt) composição compreendendo quitosana para administração ocular de vaninas em aves
IN2015KN00516A (es)
AR093424A1 (es) Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso
PH12016500360A1 (en) A bacterial vaccine and methods for manufacture thereof
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
WO2015051371A3 (en) Haemophilus parasuis vaccine serovar type four
MY177587A (en) Multivalent vlp conjugates
NZ589981A (en) Cattle vaccines comprising a disrupted M. bovis bacterium
BR112014020025A2 (pt) vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas
GB2515222A (en) Use of flagellin as a vaccine
BR112015018330A2 (pt) cepas de flavobacterium vivas modificadas, vacinas estabilizadas compreendendo as mesmas, e métodos de preparo e uso das mesmas
BR112013006245A2 (pt) vacina e método para vacinação
MX364733B (es) Vacunas de salmonella de protección cruzada.
NZ717406A (en) Attenuated mannheimia haemolytica vaccines and methods of making and use

Legal Events

Date Code Title Description
FG Grant, registration